RON is overexpressed in bladder cancer and contributes to tumorigenic phenotypes in 5637 cells.


Tyrosine kinase receptor macrophage stimulating 1 receptor (MST1R, also known as RON) contributes to the transformation and malignant progression observed in epithelial cells. The purpose of the present study is to assess the value of RON as a potential target in bladder cancer (BC) therapeutics. The expression profile of RON in BC tissues and adjacent… (More)
DOI: 10.3892/ol.2018.8135


  • Presentations referencing similar topics